News
Danish pharma company, Novo Nordisk, plans to hire another 1000 staff in the emerging markets over the next two years. Novo Nordisk has announced its plans to expand treatments for diabetes in emerging markets by hiring…
Phase 2 clinical trials of Merck’s once-a-week diabetes treatment, MK-3102, showed statistically significant results. Merck & Co has announced that phase 2 clinical trials of its investigational once-weekly DPP-4 inhibitor, in development for…
Sanofi and Bristol-Myers Squibb revamp their 15-year alliance as of January 2013, following the loss of exclusivity on two key drugs and a rise in generic competition. Sanofi and Bristol-Myers Squibb have announced they are restructuring their successful long-term alliance. This announcement follows…
Biopharmaceutical company, GeoVax, has been awarded a grant to continue developing clade B and C vaccines for the HIV virus in both developed and developing countries. The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, have awarded a US $1.9 million grant…
Japanese pharma company Takeda and Danish Lundbeck jointly seek FDA approval for their antidepressant drug, vortioxetine. Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA) to the…
Novartis’ Seebri Breezhaler, to treat patients with COPD, has been approved for use in Europe. The European Commission has approved Novartis’ Seebri Breezhaler to relieve symptoms in adult patients with chronic…
Abbott’s blockbuster rheumatoid arthritis drug, Humira, has been approved by the US FDA for a new use – to treat patients with moderate to severe ulcerative colitis. Abbott Laboratories Inc.’s drug, Humira, has been approved for the treatment of moderate to…
Novartis’ phase 2 clinical trials show significant improvement in alleviating the symptoms for patients suffering from plaque psoriasis. Swiss pharmaceutical company Novartis has announced that a mid-stage clinical trial of a new treatment…
Stivarga, to treat patients with colorectal cancer, has been approved for use in the US by the FDA. The US FDA has approved Stivarga to treat patients with colorectal cancer, which has progress after treatment and…
